Table of Content

1 Clotting Factors Ⅷ Market Overview
1.1 Product Overview and Scope of Clotting Factors Ⅷ
1.2 Clotting Factors Ⅷ Segment by Type
1.2.1 Global Clotting Factors Ⅷ Sales Growth Rate Comparison by Type (2021-2027)
1.2.2 Injection
1.2.3 Freeze-dried Injection
1.3 Clotting Factors Ⅷ Segment by Application
1.3.1 Clotting Factors Ⅷ Sales Comparison by Application: (2021-2027)
1.3.2 Hemophilia A
1.3.3 Bleeding Diseases
1.4 Global Clotting Factors Ⅷ Market Size Estimates and Forecasts
1.4.1 Global Clotting Factors Ⅷ Revenue 2016-2027
1.4.2 Global Clotting Factors Ⅷ Sales 2016-2027
1.4.3 Clotting Factors Ⅷ Market Size by Region: 2016 Versus 2021 Versus 2027

2 Clotting Factors Ⅷ Market Competition by Manufacturers
2.1 Global Clotting Factors Ⅷ Sales Market Share by Manufacturers (2016-2021)
2.2 Global Clotting Factors Ⅷ Revenue Market Share by Manufacturers (2016-2021)
2.3 Global Clotting Factors Ⅷ Average Price by Manufacturers (2016-2021)
2.4 Manufacturers Clotting Factors Ⅷ Manufacturing Sites, Area Served, Product Type
2.5 Clotting Factors Ⅷ Market Competitive Situation and Trends
2.5.1 Clotting Factors Ⅷ Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Clotting Factors Ⅷ Players Market Share by Revenue
2.5.3 Global Clotting Factors Ⅷ Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Clotting Factors Ⅷ Retrospective Market Scenario by Region
3.1 Global Clotting Factors Ⅷ Retrospective Market Scenario in Revenue by Region: 2016-2021
3.2 Global Clotting Factors Ⅷ Retrospective Market Scenario in Sales by Region: 2016-2021
3.3 North America Clotting Factors Ⅷ Market Facts & Figures by Country
3.3.1 North America Clotting Factors Ⅷ Sales by Country
3.3.2 North America Clotting Factors Ⅷ Revenue by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Clotting Factors Ⅷ Market Facts & Figures by Country
3.4.1 Europe Clotting Factors Ⅷ Sales by Country
3.4.2 Europe Clotting Factors Ⅷ Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Clotting Factors Ⅷ Market Facts & Figures by Region
3.5.1 Asia Pacific Clotting Factors Ⅷ Sales by Region
3.5.2 Asia Pacific Clotting Factors Ⅷ Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Clotting Factors Ⅷ Market Facts & Figures by Country
3.6.1 Latin America Clotting Factors Ⅷ Sales by Country
3.6.2 Latin America Clotting Factors Ⅷ Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa Clotting Factors Ⅷ Market Facts & Figures by Country
3.7.1 Middle East and Africa Clotting Factors Ⅷ Sales by Country
3.7.2 Middle East and Africa Clotting Factors Ⅷ Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 UAE
4 Global Clotting Factors Ⅷ Historic Market Analysis by Type
4.1 Global Clotting Factors Ⅷ Sales Market Share by Type (2016-2021)
4.2 Global Clotting Factors Ⅷ Revenue Market Share by Type (2016-2021)
4.3 Global Clotting Factors Ⅷ Price by Type (2016-2021)

5 Global Clotting Factors Ⅷ Historic Market Analysis by Application
5.1 Global Clotting Factors Ⅷ Sales Market Share by Application (2016-2021)
5.2 Global Clotting Factors Ⅷ Revenue Market Share by Application (2016-2021)
5.3 Global Clotting Factors Ⅷ Price by Application (2016-2021)

6 Key Companies Profiled
6.1 Lvshizi
6.1.1 Lvshizi Corporation Information
6.1.2 Lvshizi Description and Business Overview
6.1.3 Lvshizi Clotting Factors Ⅷ Sales, Revenue and Gross Margin (2016-2021)
6.1.4 Lvshizi Product Portfolio
6.1.5 Lvshizi Recent Developments/Updates
6.2 Taibang Biological
6.2.1 Taibang Biological Corporation Information
6.2.2 Taibang Biological Description and Business Overview
6.2.3 Taibang Biological Clotting Factors Ⅷ Sales, Revenue and Gross Margin (2016-2021)
6.2.4 Taibang Biological Product Portfolio
6.2.5 Taibang Biological Recent Developments/Updates
6.3 Shanghai Laishi
6.3.1 Shanghai Laishi Corporation Information
6.3.2 Shanghai Laishi Description and Business Overview
6.3.3 Shanghai Laishi Clotting Factors Ⅷ Sales, Revenue and Gross Margin (2016-2021)
6.3.4 Shanghai Laishi Product Portfolio
6.3.5 Shanghai Laishi Recent Developments/Updates
6.4 Hualan Biological
6.4.1 Hualan Biological Corporation Information
6.4.2 Hualan Biological Description and Business Overview
6.4.3 Hualan Biological Clotting Factors Ⅷ Sales, Revenue and Gross Margin (2016-2021)
6.4.4 Hualan Biological Product Portfolio
6.4.5 Hualan Biological Recent Developments/Updates

7 Clotting Factors Ⅷ Manufacturing Cost Analysis
7.1 Clotting Factors Ⅷ Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Clotting Factors Ⅷ
7.4 Clotting Factors Ⅷ Industrial Chain Analysis

8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Clotting Factors Ⅷ Distributors List
8.3 Clotting Factors Ⅷ Customers

9 Clotting Factors Ⅷ Market Dynamics
9.1 Clotting Factors Ⅷ Industry Trends
9.2 Clotting Factors Ⅷ Growth Drivers
9.3 Clotting Factors Ⅷ Market Challenges
9.4 Clotting Factors Ⅷ Market Restraints

10 Global Market Forecast
10.1 Clotting Factors Ⅷ Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Clotting Factors Ⅷ by Type (2022-2027)
10.1.2 Global Forecasted Revenue of Clotting Factors Ⅷ by Type (2022-2027)
10.2 Clotting Factors Ⅷ Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Clotting Factors Ⅷ by Application (2022-2027)
10.2.2 Global Forecasted Revenue of Clotting Factors Ⅷ by Application (2022-2027)
10.3 Clotting Factors Ⅷ Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Clotting Factors Ⅷ by Region (2022-2027)
10.3.2 Global Forecasted Revenue of Clotting Factors Ⅷ by Region (2022-2027)

11 Research Finding and Conclusion

12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer

List of Figure

List of Tables
Table 1. Global Clotting Factors Ⅷ Sales (K Units) Growth Rate Comparison by Type (2021-2027)
Table 2. Global Clotting Factors Ⅷ Sales (K Units) Comparison by Application (2021-2027)
Table 3. Global Clotting Factors Ⅷ Market Size by Region (US$ Million) (2016 VS 2021 VS 2027)
Table 4. Key Manufacturers Clotting Factors Ⅷ Covered in This Study
Table 5. Global Clotting Factors Ⅷ Sales (K Units) of Key Manufacturers (2016-2021)
Table 6. Global Clotting Factors Ⅷ Sales Share by Manufacturers (2016-2021)
Table 7. Global Clotting Factors Ⅷ Revenue (US$ Million) by Manufacturers (2016-2021)
Table 8. Global Clotting Factors Ⅷ Revenue Share by Manufacturers (2016-2021)
Table 9. Global Market Clotting Factors Ⅷ Average Price (US$/Unit) of Key Manufacturers (2016-2021)
Table 10. Manufacturers Clotting Factors Ⅷ Manufacturing Sites and Area Served
Table 11. Manufacturers Clotting Factors Ⅷ Product Type
Table 12. Global Clotting Factors Ⅷ Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Clotting Factors Ⅷ by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Clotting Factors Ⅷ as of 2020)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Global Clotting Factors Ⅷ Sales by Region (2016-2021) & (K Units)
Table 16. Global Clotting Factors Ⅷ Sales Market Share by Region (2016-2021)
Table 17. Global Clotting Factors Ⅷ Revenue by Region (2016-2021) & (US$ Million)
Table 18. North America Clotting Factors Ⅷ Sales by Country (2016-2021) & (K Units)
Table 19. North America Clotting Factors Ⅷ Sales Market Share by Country (2016-2021)
Table 20. North America Clotting Factors Ⅷ Revenue by Country (2016-2021) & (US$ Million)
Table 21. North America Clotting Factors Ⅷ Revenue Market Share by Country (2016-2021)
Table 22. Europe Clotting Factors Ⅷ Sales by Country (2016-2021) & (K Units)
Table 23. Europe Clotting Factors Ⅷ Sales Market Share by Country (2016-2021)
Table 24. Europe Clotting Factors Ⅷ Revenue by Country (2016-2021) & (US$ Million)
Table 25. Europe Clotting Factors Ⅷ Revenue Market Share by Country (2016-2021)
Table 26. Asia Pacific Clotting Factors Ⅷ Sales by Region (2016-2021) & (K Units)
Table 27. Asia Pacific Clotting Factors Ⅷ Sales Market Share by Region (2016-2021)
Table 28. Asia Pacific Clotting Factors Ⅷ Revenue by Region (2016-2021) & (US$ Million)
Table 29. Asia Pacific Clotting Factors Ⅷ Revenue Market Share by Region (2016-2021)
Table 30. Latin America Clotting Factors Ⅷ Sales by Country (2016-2021) & (K Units)
Table 31. Latin America Clotting Factors Ⅷ Sales Market Share by Country (2016-2021)
Table 32. Latin America Clotting Factors Ⅷ Revenue by Country (2016-2021) & (US$ Million)
Table 33. Latin America Clotting Factors Ⅷ Revenue Market Share by Country (2016-2021)
Table 34. Middle East and Africa Clotting Factors Ⅷ Sales by Country (2016-2021) & (K Units)
Table 35. Middle East and Africa Clotting Factors Ⅷ Sales Market Share by Country (2016-2021)
Table 36. Middle East and Africa Clotting Factors Ⅷ Revenue by Country (2016-2021) & (US$ Million)
Table 37. Middle East and Africa Clotting Factors Ⅷ Revenue Market Share by Country (2016-2021)
Table 38. Global Clotting Factors Ⅷ Sales (K Units) by Type (2016-2021)
Table 39. Global Clotting Factors Ⅷ Sales Market Share by Type (2016-2021)
Table 40. Global Clotting Factors Ⅷ Revenue (Million US$) by Type (2016-2021)
Table 41. Global Clotting Factors Ⅷ Revenue Share by Type (2016-2021)
Table 42. Global Clotting Factors Ⅷ Price (US$/Unit) by Type (2016-2021)
Table 43. Global Clotting Factors Ⅷ Sales (K Units) by Application (2016-2021)
Table 44. Global Clotting Factors Ⅷ Sales Market Share by Application (2016-2021)
Table 45. Global Clotting Factors Ⅷ Revenue (Million US$) by Application (2016-2021)
Table 46. Global Clotting Factors Ⅷ Revenue Share by Application (2016-2021)
Table 47. Global Clotting Factors Ⅷ Price (US$/Unit) by Application (2016-2021)
Table 48. Lvshizi Corporation Information
Table 49. Lvshizi Description and Business Overview
Table 50. Lvshizi Clotting Factors Ⅷ Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 51. Lvshizi Clotting Factors Ⅷ Product
Table 52. Lvshizi Recent Developments/Updates
Table 53. Taibang Biological Corporation Information
Table 54. Taibang Biological Description and Business Overview
Table 55. Taibang Biological Clotting Factors Ⅷ Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 56. Taibang Biological Clotting Factors Ⅷ Product
Table 57. Taibang Biological Recent Developments/Updates
Table 58. Shanghai Laishi Corporation Information
Table 59. Shanghai Laishi Description and Business Overview
Table 60. Shanghai Laishi Clotting Factors Ⅷ Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 61. Shanghai Laishi Clotting Factors Ⅷ Product
Table 62. Shanghai Laishi Recent Developments/Updates
Table 63. Hualan Biological Corporation Information
Table 64. Hualan Biological Description and Business Overview
Table 65. Hualan Biological Clotting Factors Ⅷ Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 66. Hualan Biological Clotting Factors Ⅷ Product
Table 67. Hualan Biological Recent Developments/Updates
Table 68. Production Base and Market Concentration Rate of Raw Material
Table 69. Key Suppliers of Raw Materials
Table 70. Clotting Factors Ⅷ Distributors List
Table 71. Clotting Factors Ⅷ Customers List
Table 72. Clotting Factors Ⅷ Market Trends
Table 73. Clotting Factors Ⅷ Growth Drivers
Table 74. Clotting Factors Ⅷ Market Restraints
Table 75. Global Clotting Factors Ⅷ Sales Forecast by Type (2022-2027) & (K Units)
Table 76. Global Clotting Factors Ⅷ Sales Market Share Forecast by Type (2022-2027)
Table 77. Global Clotting Factors Ⅷ Revenue Forecast by Type (2022-2027) & (US$ Million)
Table 78. Global Clotting Factors Ⅷ Revenue Market Share Forecast by Type (2022-2027)
Table 79. Global Clotting Factors Ⅷ Sales Forecast by Application (2022-2027) & (K Units)
Table 80. Global Clotting Factors Ⅷ Sales Market Share Forecast by Application (2022-2027)
Table 81. Global Clotting Factors Ⅷ Revenue Forecast by Application (2022-2027) & (US$ Million)
Table 82. Global Clotting Factors Ⅷ Revenue Market Share Forecast by Application (2022-2027)
Table 83. Global Clotting Factors Ⅷ Sales Forecast by Region (2022-2027) & (K Units)
Table 84. Global Clotting Factors Ⅷ Sales Market Share Forecast by Region (2022-2027)
Table 85. Global Clotting Factors Ⅷ Revenue Forecast by Region (2022-2027) & (US$ Million)
Table 86. Global Clotting Factors Ⅷ Revenue Market Share Forecast by Region (2022-2027)
Table 87. Research Programs/Design for This Report
Table 88. Key Data Information from Secondary Sources
Table 89. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Clotting Factors Ⅷ
Figure 2. Global Clotting Factors Ⅷ Market Share by Type in 2020 & 2027
Figure 3. Injection Product Picture
Figure 4. Freeze-dried Injection Product Picture
Figure 5. Global Clotting Factors Ⅷ Market Share by Application in 2020 & 2027
Figure 6. Hemophilia A
Figure 7. Bleeding Diseases
Figure 8. Global Clotting Factors Ⅷ Revenue, (US$ Million), 2016 VS 2021 VS 2027
Figure 9. Global Clotting Factors Ⅷ Market Size 2016-2027 (US$ Million)
Figure 10. Global Clotting Factors Ⅷ Sales 2016-2027 (K Units)
Figure 11. Global Clotting Factors Ⅷ Market Size Market Share by Region: 2016 VS 20210 VS 2027
Figure 12. Clotting Factors Ⅷ Sales Share by Manufacturers in 2020
Figure 13. Global Clotting Factors Ⅷ Revenue Share by Manufacturers in 2020
Figure 14. The Global 5 and 10 Largest Clotting Factors Ⅷ Players: Market Share by Revenue in 2020
Figure 15. Clotting Factors Ⅷ Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2021
Figure 16. Global Clotting Factors Ⅷ Sales Market Share by Region (2016-2021)
Figure 17. Global Clotting Factors Ⅷ Sales Market Share by Region in 2020
Figure 18. Global Clotting Factors Ⅷ Revenue Market Share by Region (2016-2021)
Figure 19. Global Clotting Factors Ⅷ Revenue Market Share by Region in 2020
Figure 20. U.S. Clotting Factors Ⅷ Revenue Growth Rate (2016-2021) (US$ Million)
Figure 21. Canada Clotting Factors Ⅷ Revenue Growth Rate (2016-2021) (US$ Million)
Figure 22. Germany Clotting Factors Ⅷ Revenue Growth Rate (2016-2021) (US$ Million)
Figure 23. France Clotting Factors Ⅷ Revenue Growth Rate (2016-2021) (US$ Million)
Figure 24. U.K. Clotting Factors Ⅷ Revenue Growth Rate (2016-2021) (US$ Million)
Figure 25. Italy Clotting Factors Ⅷ Revenue Growth Rate (2016-2021) (US$ Million)
Figure 26. Russia Clotting Factors Ⅷ Revenue Growth Rate (2016-2021) (US$ Million)
Figure 27. China Clotting Factors Ⅷ Revenue Growth Rate (2016-2021) (US$ Million)
Figure 28. Japan Clotting Factors Ⅷ Revenue Growth Rate (2016-2021) (US$ Million)
Figure 29. South Korea Clotting Factors Ⅷ Revenue Growth Rate (2016-2021) (US$ Million)
Figure 30. India Clotting Factors Ⅷ Revenue Growth Rate (2016-2021) (US$ Million)
Figure 31. Australia Clotting Factors Ⅷ Revenue Growth Rate (2016-2021) (US$ Million)
Figure 32. Taiwan Clotting Factors Ⅷ Revenue Growth Rate (2016-2021) (US$ Million)
Figure 33. Indonesia Clotting Factors Ⅷ Revenue Growth Rate (2016-2021) (US$ Million)
Figure 34. Thailand Clotting Factors Ⅷ Revenue Growth Rate (2016-2021) (US$ Million)
Figure 35. Malaysia Clotting Factors Ⅷ Revenue Growth Rate (2016-2021) (US$ Million)
Figure 36. Philippines Clotting Factors Ⅷ Revenue Growth Rate (2016-2021) (US$ Million)
Figure 37. Vietnam Clotting Factors Ⅷ Revenue Growth Rate (2016-2021) (US$ Million)
Figure 38. Mexico Clotting Factors Ⅷ Revenue Growth Rate (2016-2021) (US$ Million)
Figure 39. Brazil Clotting Factors Ⅷ Revenue Growth Rate (2016-2021) (US$ Million)
Figure 40. Argentina Clotting Factors Ⅷ Revenue Growth Rate (2016-2021) (US$ Million)
Figure 41. Turkey Clotting Factors Ⅷ Revenue Growth Rate (2016-2021) (US$ Million)
Figure 42. Saudi Arabia Clotting Factors Ⅷ Revenue Growth Rate (2016-2021) (US$ Million)
Figure 43. UAE Clotting Factors Ⅷ Revenue Growth Rate (2016-2021) (US$ Million)
Figure 44. Sales Market Share of Clotting Factors Ⅷ by Type (2016-2021)
Figure 45. Sales Market Share of Clotting Factors Ⅷ by Application (2016-2021)
Figure 46. Sales Market Share of Clotting Factors Ⅷ by Application in 2020
Figure 47. Revenue Share of Clotting Factors Ⅷ by Application (2016-2021)
Figure 48. Revenue Share of Clotting Factors Ⅷ by Application in 2020
Figure 49. Manufacturing Cost Structure of Clotting Factors Ⅷ
Figure 50. Manufacturing Process Analysis of Clotting Factors Ⅷ
Figure 51. Clotting Factors Ⅷ Industrial Chain Analysis
Figure 52. Channels of Distribution
Figure 53. Distributors Profiles
Figure 54. Bottom-up and Top-down Approaches for This Report
Figure 55. Data Triangulation
Figure 56. Key Executives Interviewed